Aton Pharma has launched Lacrisert (hydroxypropyl cellulose ophthalmic insert) for the treatment of moderate-to-severe dry eye syndromes. Lacrisert is being made readily available through an expanded distribution program and is offered in kits containing 60 sterile unit doses, 2 reusable applicators, and a storage container.

For more information call (877) ATON-549 or visit www.lacrisert.com.